Do you want to showcase your research at #CEPAS?
The abstract deadline is 1 April!
Find all info how to submit here👇
https://www.cepas.org/abstracts
We have become a partner of the #CEPAS conference 28-31 Oct 2026, organised by @ESPR_ESN , EAP and GFCNI.
Through this partnership, we will help amplify the reach and discussions of CEPAS within our global neonatal community, incl the #nicuverse.
Our team will also be present on site, and run #NeoMastodon live coverage of the most interesting session!
https://99nicu.org/blogs/entry/448-99nicu-becomes-a-partner-of-the-cepas-conference-28-31-oct-2026/
We are pleased to announce that the 99NICU Community has become an official partner of the CEPAS Conference, 28-31 Oct 2026.CEPAS is an international conference dedicated to advancing knowledge and collaboration in neonatal and pediatric care, a new biennial meeting of the European Academy of Pae...
Have you cared for a patient with multiple unilateral missing ribs leading to chest wall instability? Please share your experience and know-how in this new thread, link below:
https://99nicu.org/forums/topic/2894-congenital-rib-agenesis-chest-wall-disorder/
The #PREMILOC strategy (low-dose hydrocortisone to prevent BPD) seems to work also in Sweden (no surprise!). An observational study based on national register data out now in JAMA Ped finds higher chance of BPD-free survival and lower BPD-risk (somewhat modest shifts in absolute risks, but still!).
Thank you @ulrade for a nice project and publication! Time for Stockholm to adopt this now?!
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2845265
Are you interested in resources for checking medication compatibility with breastfeeding?
The thread below, started by @aprendizdeprematuros , contains a lot!
I’d love to hear from the 99NICU community about your go-to references.A few years ago, our team cared for a remarkable mother whose story reminded us how much nuance—and teamwork—breastfeeding counseling can require. She had undergone a liver transplant as a teenager and remained on lifelong ant...
The #TREOCAPA trial is out, comparing paracetamol vs placebo for prophylactic tx of the PDA in infants <29w. More ducts closed but no diff in disease free survival…
More confusion on a higher level?!
Interesting to see some numbers on the large international variations of feeding / nutrition practises for preterm infants. More research is needed, but also some more action!
https://fn.bmj.com/content/early/2026/02/12/archdischild-2025-329670.long
Objective To evaluate enteral feeding practices in preterm infants in neonatal intensive care units (NICUs) in high-income countries across three continents, and compare results with a similar survey 13 years earlier. Methods Web-based survey distributed to neonatologists at 258 NICUs across 15 countries in Europe, Australia, New Zealand and Canada, October 2023 and February 2024. Survey domains focused on availability of human milk, onset of enteral feeding, breast milk fortification (BMF), cytomegalovirus (CMV) screening and enteral supplements including probiotics. Results were compared with a similar survey performed in 2010. Results Replies were received from 185 (72%) NICUs. Access to donor human milk (DHM) was high (91%). Across all NICUs, feeds were started on day 1 in 64%, 73% and 85% among infants born <25, 25–27 and 28–31 weeks’ gestation, respectively. Bovine milk-based BMF was routinely used in 88% of NICUs, with large variation in when it was commenced and discontinued. Routine use of human milk-based BMF was uncommon (4%). Maternal CMV status was routinely determined in 33% of all NICUs who then pasteurised or froze milk if the mother was CMV-seropositive. Probiotics were provided in 66% of the NICUs, with large variations in products and birth weight/gestational age criteria. Conclusions Compared with our survey from 2010, more NICUs now start feeding preterm infants on day 1, and DHM availability has increased in some countries. Substantial variation remains in the use of BMF, probiotics and CMV screening. A stronger evidence base is needed to update guidelines, aiming ultimately to improve growth and long-term neurodevelopment. Data are available upon reasonable request. The raw data supporting the conclusion of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.
Acta Paediatrica
99nicu
Stefan Johansson, MD PhD